Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald J Kyle

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Peptide Science : an Official Publication of the European Peptide Society|May 19, 2012
Cysteine racemization during the Fmoc solid phase peptide synthesis of the Nav1.7-selective peptide--protoxin IIJae H Park, Kevin P Carlin, Gang Wu, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Design and synthesis of 4-phenyl piperidine compounds targeting the mu receptorZhengming Chen, Ellen Davies, Wendy S Miller, et al.
Biochemistry|November 27, 2002
Human B1 and B2 bradykinin receptors and their agonists target caveolae-related lipid rafts to different degrees in HEK293 cellsMaria E Lamb, Chongwu Zhang, Thomas Shea, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2014
N-Aryl azacycles as novel sodium channel blockersStephen M Lynch, Laykea Tafesse, Kevin Carlin, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonistsLaykea Tafesse, Qun Sun, Lori Schmid, et al.
Journal of Medicinal Chemistry|July 16, 2014
Studies examining the relationship between the chemical structure of protoxin II and its activity on voltage gated sodium channelsJae H Park, Kevin P Carlin, Gang Wu, et al.
Journal of Medicinal Chemistry|February 18, 2005
8-Substituted analogues of 3-(3-cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl-adenine: highly potent and selective PDE4 inhibitorsJohn W F Whitehead, Gary P Lee, Parviz Gharagozloo, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
4-(2-pyridyl)piperazine-1-carboxamides: potent vanilloid receptor 1 antagonistsQun Sun, Laykea Tafesse, Khondaker Islam, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
1,3-Dihydro-2,1,3-benzothiadiazol-2,2-diones and 3,4-dihydro-1H-2,1,3-benzothidiazin-2,2-diones as ligands for the NOP receptorR Richard Goehring, John F W Whitehead, K Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2004
DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: I. In vitro pharmacological characterization and pharmacokinetic propertiesKenneth J Valenzano, Wendy Miller, Zhengming Chen, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Peptide Science : an Official Publication of the European Peptide Society|May 19, 2012
Cysteine racemization during the Fmoc solid phase peptide synthesis of the Nav1.7-selective peptide--protoxin IIJae H Park, Kevin P Carlin, Gang Wu, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Design and synthesis of 4-phenyl piperidine compounds targeting the mu receptorZhengming Chen, Ellen Davies, Wendy S Miller, et al.
Biochemistry|November 27, 2002
Human B1 and B2 bradykinin receptors and their agonists target caveolae-related lipid rafts to different degrees in HEK293 cellsMaria E Lamb, Chongwu Zhang, Thomas Shea, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2014
N-Aryl azacycles as novel sodium channel blockersStephen M Lynch, Laykea Tafesse, Kevin Carlin, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonistsLaykea Tafesse, Qun Sun, Lori Schmid, et al.
Journal of Medicinal Chemistry|July 16, 2014
Studies examining the relationship between the chemical structure of protoxin II and its activity on voltage gated sodium channelsJae H Park, Kevin P Carlin, Gang Wu, et al.
Journal of Medicinal Chemistry|February 18, 2005
8-Substituted analogues of 3-(3-cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl-adenine: highly potent and selective PDE4 inhibitorsJohn W F Whitehead, Gary P Lee, Parviz Gharagozloo, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
4-(2-pyridyl)piperazine-1-carboxamides: potent vanilloid receptor 1 antagonistsQun Sun, Laykea Tafesse, Khondaker Islam, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
1,3-Dihydro-2,1,3-benzothiadiazol-2,2-diones and 3,4-dihydro-1H-2,1,3-benzothidiazin-2,2-diones as ligands for the NOP receptorR Richard Goehring, John F W Whitehead, K Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2004
DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: I. In vitro pharmacological characterization and pharmacokinetic propertiesKenneth J Valenzano, Wendy Miller, Zhengming Chen, et al.
Pageof 3